[Triplet anti-tumor therapy based on thymosin α-1 attenuates incidence of hepatoma and serum alpha-fetoprotein level in rat hepatoma model].
Lists
Only you see this
Abstract
The triple anti-tumor therapy can significantly prolong the survival time of rats with liver cancer, decrease the cancer incidence rate and the level of serum AFP.
BibTeX
@inproceedings{fu2015triplet,
author = {Xiaoqian Fu and Yuxiang Wei and De‐Hua Zheng and Lin Zhou and Zhidong Zhu and Jiyong Song and Likui Feng and Guosheng Du},
title = {{[Triplet anti-tumor therapy based on thymosin α-1 attenuates incidence of hepatoma and serum alpha-fetoprotein level in rat hepatoma model].}},
booktitle = {PubMed},
year = {2015},
}Loading related content...